Possible mechanisms underlying the development of cachexia in COPD

Wagner P. D.

Source: Eur Respir J 2008; 31: 492-501
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Wagner P. D.. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008; 31: 492-501

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006



Hormonal changes and catabolic/anabolic imbalance in chronic obstructive pulmonary disease and their importance for pulmonary cachexia
Source: Eur Respir J 2002; 20: Suppl. 38, 202s
Year: 2002

Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Investigating the fatigue and related factors in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017


Accelerated ageing and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Year: 2003


Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009



Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012



Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012



Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Systemic inflammation in chronic respiratory disease
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=46
Year: 2003

Inflammation and depression in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 718s
Year: 2007

Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006


The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Cytokine-induced mechanisms of osteopenic syndrome in the chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001

Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016


Mechanisms of ECG changes in chronic obstructive pulmonary disease
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Skeletal muscle dysfunction and the related mechanism in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009